title: Responsiveness of choroidal neovascular membranes in patients with R345W mutation in fibulin 3 (Doyne honeycomb retinal dystrophy) to anti-vascular endothelial growth factor therapy.
authors.affiliation: Ophthalmology/Retina, University of Iowa, 200 Hawkins Dr PFP, Iowa City, IA 52242, USA. elliott.sohn@gmail.com
authors.forename: Elliott H
authors.initials: EH
authors.lastname: Sohn
authors.forename: Praveen J
authors.initials: PJ
authors.lastname: Patel
authors.forename: Robert E
authors.initials: RE
authors.lastname: MacLaren
authors.forename: Feisal A
authors.initials: FA
authors.lastname: Adatia
authors.forename: Bishwanath
authors.initials: B
authors.lastname: Pal
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Webster
authors.forename: Adnan
authors.initials: A
authors.lastname: Tufail
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000235:genetics; D003317:Corneal Dystrophies, Hereditary / Q000188:drug therapy* / Q000235:genetics; D016326:Extracellular Matrix Proteins / Q000235:genetics*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D015594:Optic Disk Drusen / Q000151:congenital; D017354:Point Mutation; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C119630:EFEMP1 protein, human; D016326:Extracellular Matrix Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab